{
  "paper_metadata": {
    "pmid": "29021639",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for BRCA2, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3034delACAA",
      "protein_notation": "p.?",
      "genomic_position": "string or null",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 8,
        "demographics": "Colombian population, female patients with breast cancer",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 8,
        "affected_count": 8,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Pathogenic mutation associated with breast cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence based on clinical significance.",
      "source_location": "Table 1, Row 3",
      "additional_notes": "This variant is one of the previously defined founder mutations.",
      "key_quotes": [
        "Among these, 24 were identified in BRCA1, in addition to the G5337A polymorphism, which, given its high prevalence, requires further study to determine its clinical implication.",
        "The most frequent mutations in BRCA2 were 3034delACAA (8 patients), followed by C5972T (11 patients)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6076delGTTA",
      "protein_notation": "p.?",
      "genomic_position": "string or null",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Colombian population, female patients with breast cancer",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Pathogenic mutation associated with breast cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence based on clinical significance.",
      "source_location": "Table 1, Row 4",
      "additional_notes": "This variant is one of the previously defined founder mutations.",
      "key_quotes": [
        "The most frequent mutations in BRCA2 were 3034delACAA (8 patients), followed by C5972T (11 patients)."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.6503delTT",
      "protein_notation": "p.?",
      "genomic_position": "string or null",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 0,
        "demographics": "",
        "phenotype": ""
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Pathogenic mutation associated with breast cancer.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified",
      "evidence_level": "Not specified",
      "source_location": "Table 1, Row 5",
      "additional_notes": "This variant is one of the previously defined founder mutations.",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.W31X",
      "protein_notation": "p.?",
      "genomic_position": "string or null",
      "clinical_significance": "Pending",
      "patients": {
        "count": 0,
        "demographics": "",
        "phenotype": ""
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Pending clinical significance.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified",
      "evidence_level": "Not specified",
      "source_location": "Table 1, Row 6",
      "additional_notes": "This variant is one of the previously defined founder mutations.",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.C3046T",
      "protein_notation": "p.?",
      "genomic_position": "string or null",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Colombian population, female patients with breast cancer",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Pathogenic mutation associated with breast cancer.",
        "assays": []
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence based on clinical significance.",
      "source_location": "Table 1, Row 7",
      "additional_notes": "This variant is one of the previously defined founder mutations.",
      "key_quotes": []
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.V572L",
      "protein_notation": "p.?",
      "genomic_position": "string or null",
      "clinical_significance": "Likely benign",
      "patients": {
        "count": 1,
        "demographics": "Colombian population, female patients with breast cancer",
        "phenotype": "Breast cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Likely benign mutation.",
        "assays": []
      },
      "segregation_data": "Not specified.",
      "population_frequency": "Not specified",
      "evidence_level": "Not specified",
      "source_location": "Table 1, Row 8",
      "additional_notes": "This variant is one of the previously defined founder mutations.",
      "key_quotes": []
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Mutations detected in BRCA1 and BRCA2 in Colombia and their clinical relevance according to NCBI (NIH-BIC and ClinVar).",
      "variants_extracted": 6
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 6,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants were extracted successfully."
  }
}